4.6 Article

Remote ischemic conditioning protects against endothelial ischemia-reperfusion injury via a glucagon-like peptide-1 receptor-mediated mechanism in humans

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 274, Issue -, Pages 40-44

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2018.09.061

Keywords

Cardioprotection; Endothelial function; Flow-mediated dilatation; Glucagon-like peptide-1; Ischemia-reperfusion; Remote ischemic conditioning

Funding

  1. Swedish Research Council [201601284]
  2. Swedish Heart-Lung Foundation [20160239]
  3. Stockholm County Council [20160084]
  4. Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme [20120741]
  5. Soderberg Foundation [M60/15]
  6. Diabetes Research & Wellness Foundation [720-1519-16]

Ask authors/readers for more resources

Background: Remote ischemic conditioning (RIC), i.e. short cycles of ischemia and reperfusion in remote tissue, is a novel approach to protect against myocardial ischemia-reperfusion injury in ST-elevation myocardial infarction. The nature of the factors transmitting the protective effect of RIC remains unknown, and both neuronal and hormonal mechanisms appear to be involved. A recent study indicated involvement of glucagon-like peptide-1 (GLP-1) regulated by the vagal nerve in RIC in rats. In the present study we aimed to investigate whether the protective effect of RIC is mediated by a GLP-1 receptor-dependent mechanism in humans. Methods: Endothelial function was determined from flow-mediated dilatation (FMD) of the brachial artery before and after 20 min of forearm ischemia and 20 min of reperfusion in twelve healthy subjects on three occasions: (A) ischemia-reperfusion without intervention, (B) ischemia-reperfusion + RIC and (C) iv administration of the GLP-1 receptor antagonist exendin(9-39) + ischemia-reperfusion + RIC. Results: Ischemia-reperfusion reduced FMD from 4.7 +/- 0.8% at baseline to 1.5 +/- 0.4% (p < 0.01). RIC protected from the impairment in FMD induced by ischemia-reperfusion (4.6 +/- 1.1% at baseline vs. 5.0 +/- 1.1% following ischemia-reperfusion). Exendin(9-39) abolished the protection induced by RIC (FMD 4.9 +/- 0.9% at baseline vs. 1.4 +/- 1.3% following ischemia-reperfusion; p < 0.01) but did not affect basal FMD. Plasma GLP-1 levels did not change significantly between examinations. Conclusion: The present study is the first to suggest that RIC protects against endothelial ischemia-reperfusion injury via a GLP-1 receptor-mediated mechanism in humans. (c) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available